View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Neuroendocrinology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 21, 2021
3 min read
Save

Neuroendocrine tumors require individualized treatment approach

Neuroendocrine tumors require individualized treatment approach

Patients with neuroendocrine tumors are at greater risk for cancer-associated death compared with death due to other causes; however, mortality rates vary according to tumor site.

SPONSORED CONTENT
October 11, 2021
1 min read
Save

Dentists, orthodontists play key role in recognizing facial manifestations of acromegaly

Dentists, orthodontists play key role in recognizing facial manifestations of acromegaly

Dentists and orthodontists are uniquely positioned to identify the early facial manifestations of acromegaly, though new survey data suggest more awareness of the condition is needed to improve early diagnoses.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
August 26, 2021
2 min read
Save

FDA approves first once-weekly injection for pediatric GH deficiency

FDA approves first once-weekly injection for pediatric GH deficiency

The FDA approved the first once-weekly formulation of somatropin for children with growth hormone deficiency, according to an industry press release.

SPONSORED CONTENT
August 24, 2021
2 min read
Save

ACROSTUDY: Pegvisomant safe, effective for long-term use in acromegaly

ACROSTUDY: Pegvisomant safe, effective for long-term use in acromegaly

Real-world data from the long-term ACROSTUDY show the growth hormone receptor agonist pegvisomant is safe and effective, with a low incidence of liver enzyme elevation and no increase in tumor size for most patients with acromegaly.

SPONSORED CONTENT
August 10, 2021
3 min read
Save

Experts offer recommendations for management of pituitary tumors

Experts offer recommendations for management of pituitary tumors

An international panel reached consensus for pre- and postoperative endocrine testing to manage adults undergoing transsphenoidal surgery, including measurement of prolactin and insulin-like growth factor I levels for all pituitary tumors.

SPONSORED CONTENT
May 27, 2021
2 min read
Save

Oral octreotide associated with better quality of life, work productivity in acromegaly

Oral octreotide associated with better quality of life, work productivity in acromegaly

Adults with acromegaly reported improved quality of life and more work productivity after transitioning from injectable somatostatin receptor ligands to oral octreotide capsules, according to MPOWERED phase 3 trial data.

SPONSORED CONTENT
May 13, 2021
1 min read
Save

FDA accepts NDA for novel Cushing’s syndrome treatment

FDA accepts NDA for novel Cushing’s syndrome treatment

The FDA accepted for review a new drug application for the steroidogenesis inhibitor levoketoconazole for the treatment of endogenous Cushing’s syndrome, according to an industry press release.

SPONSORED CONTENT
April 08, 2021
4 min read
Save

Oral octreotide provides sustained biochemical control in acromegaly

Oral octreotide provides sustained biochemical control in acromegaly

Adults with acromegaly who responded to treatment with an oral form of the somatostatin analogue octreotide maintained response for an additional 48 weeks with no new safety signals observed, data from an open-label extension study show.

SPONSORED CONTENT
March 11, 2021
2 min read
Save

Cancer rate not elevated for adults with acromegaly

Cancer rate not elevated for adults with acromegaly

Adults treated for acromegaly at a medical center in Turkey do not have an increased risk for cancer compared with the general population, according to study findings published in Endocrine Practice.

SPONSORED CONTENT
February 08, 2021
4 min read
Save

Thyroid dysfunction highly prevalent in Cushing’s syndrome

Thyroid dysfunction highly prevalent in Cushing’s syndrome

Central hypothyroidism is prevalent in about 1 in 2 adults with Cushing’s syndrome, and thyroid function can be restored after curative surgery for most patients, according to study findings.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails